CTKB Deferred Revenue
Cytek Biosciences Inc · Deferred Revenue
CTKB Deferred Revenue
Latest reported$29.21Mperiod ending
CTKB Quarterly Deferred Revenue ($0.00 → $29.21M)
Quarterly deferred revenue
High-resolution chart · PNG
CTKB deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 29,206,000 | |
| 30,032,000 | |
| 29,572,000 | |
| 28,739,000 | |
| 30,010,000 | |
| 28,749,000 | |
| 26,610,000 | |
| 26,706,000 | |
| 25,037,000 | |
| 24,678,000 | |
| 24,133,000 | |
| 24,692,000 | |
| 22,150,000 | |
| 21,301,000 | |
| 14,541,000 | |
| 13,122,000 | |
| 9,991,000 | |
| 13,418,000 | |
| 8,099,000 | |
| 6,447,000 | |
| 4,699,000 | |
| 3,522,000 | |
| 4,289,000 | |
| 0 |